Prolactin
Prolactin is a hormone that is produced mostly in the anterior pituitary gland. Its production is mainly regulated by the hypothalamus by way of dopamine (dopamine inhibits PRL secretion). Prolactin is also produced by the placenta during pregnancy. The only known physiologic function of prolactin is to initiate and maintain lactation. Nonpregnant female serum prolactin is normally less than 30 ng/mL and less than 18 ng/mL in males. Normal transient elevation of prolactin can be caused by stress, exercise, or sexual activity. During pregnancy, prolactin levels can increase 10 to 20 times above baseline. Pathological elevation of prolactin (hyperprolactinemia) is generally caused by a prolactin-secreting pituitary tumor (prolactinoma). Increases in prolactin can result in galactorrhea (irregular milk production in men or women), amenorrhea (absence of menstrual cycle), and infertility and lack of libido in men and women. Other causes of hyperprolactinemia include renal failure, hypothalamic disorders or tumors, pituitary disorders, acromegaly, Cushing’s disease, hypothyroidism, and other endocrine disorders. Initial treatment of hyperprolactinemia caused by a prolactinoma includes a dopamine agonist such as bromocriptine or cabergoline. These agonists generally shrink the tumor and lower prolactin levels. Surgery or radiation therapy may be necessary if pharmaceutical treatment is not effective.
- Evaluate anterior pituitary function (along with other hormones)
- Evaluation of galactorrhea and amenorrhea
- Evaluation of infertility in females
- Evaluation of impotence and hypogonadism in males
- Diagnose prolactinomas
- Monitor treatment of prolactinomas and detect recurrences
Increased in:
- Nursing
- During pregnancy
- Renal failure
- Liver disease/cirrhosis
- Hypothyroidism, primary
- Pituitary tumors, some
- Hypothalamic-pituitary diseases (e.g., sarcoidosis, craniopharyngioma, empty sella syndrome, etc)
- Also might be increased in HIV infection
- Systemic Lupus Erythematosus
- Advanced multiple myeloma
- Stress
- Anorexia nervosa
- Polycystic ovary syndrome
- Insulin-induced hypoglycemia
- Adrenal insufficiency
- Rathke cleft cyst
- Three fourths of patients with amenorrhea and galactorrhea
- Chiari-Frommel and Argonz Del Castillo syndromes
- Some drugs such as phenothiazines, haloperidol, risperidone, reserpine, methyldopa, estrogens, tricyclic antidepressants, opiates, and cimetidine can elevate levels
Decreased in:
- Some drugs such as levodopa
- Pituitary apoplexy (Sheehan's syndrome)
Serum Reference Values
Unit: ng/mL or mg/L
| Group | Reference Range (ng/mL or mg/L) |
| Cord blood | 45–539 |
| Newborn (1–7 days) | 30–495 |
| Children (by Tanner Stage) | |
| Stage 1 – Male | <10 |
| Stage 1 – Female | 3.6–12 |
| Stage 2–3 – Male | 6.1 |
| Stage 2–3 – Female | 2.6–18 |
| Stage 4–5 – Male | 2.8–11.0 |
| Stage 4–5 – Female | 3.2–20 |
| Adult Male | 3.0–14.7 |
| Adult Female | 3.8–23.2 |
| Pregnancy (3rd trimester) | 95–473 |
Amniotic Fluid
Low concentrations are present before 12 weeks of gestation. Levels increase rapidly to peak values of 2000–3000 ng/mL (2–3 mg/L) between 15–20 weeks of gestation, then decrease gradually during the last trimester.
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum gel (SST), amniotic fluid.
Collect 3-4 hours after patient has awakened.
Overnight fasting is preferred.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Endocrinol Metab Clin North Am. 1992 Dec;21(4):877-901. [PMID: 1486880]
- J Mammary Gland Biol Neoplasia. 1997 Jan;2(1):59-68. [PMID: 10887520]
- J Clin Endocrinol Metab. 2002;87:581. [PMID: 11836289]
- J Clin Psychiatry. 2002;63 (Suppl 4):56. [PMID: 11913677]
- Mayo Clinic Proc. 2005;80:1050. [PMID: 16092584]
- Prolactin, Serum. In Mayo Interpretive Handbook.Rochester: Mayo Medical Laboratories (2009).
- Practical evaluation of hormonal status, in Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, edited by SSC Yen and RB Jaffe. Philadelphia, WB Saunders Company (1978). p 493
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757